Antidiabetic therapy at admission and survival in diabetic patients with acute myocardial infarction

The use of DPP-4 inhibitors at admission, in patients with Diabetes mellitus admitted for acute myocardial infarction, was not associated to a different survival after no less than 36 months and up to 52 months after admission.